Rubius Therapeutics

The 2023 Biotech Graveyard
Fierce Biotech
Tue, 10/31/23 - 11:34 am
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
After a Standout IPO and Series of Pivots, Rubius Closes its Doors
BioSpace
Wed, 02/22/23 - 10:11 am
Rubius Therapeutics
Former Rubius CEO to lead buzzy Flagship startup
BioPharma Dive
Thu, 11/17/22 - 11:33 pm
Rubius Therapeutics
Flagship Pioneering
startups
Laronde
Rubius’s New Cell Therapy Strategy Runs Out of Time & Money; Workforce Is Cut by 82%
MedCity News
Wed, 11/2/22 - 11:07 pm
Rubius Therapeutics
cell therapy
layoffs
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
Rubius makes hard pivot after reviewing clinical data, dumping lead assets and laying off 75% of staffers
Fierce Biotech
Tue, 09/13/22 - 10:44 am
Rubius Therapeutics
cell therapy
layoffs
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
Rubius launches $200m IPO to fund red blood cell therapies
Pharmaforum
Wed, 03/17/21 - 10:40 am
Rubius Therapeutics
IPOs
cell therapy
No knockout blow from Rubius
EP Vantage
Tue, 03/16/21 - 12:01 am
Rubius Therapeutics
RTX-240
clinical trials
cancer
3 Biotech Start-Ups That Could Soar in 2020
Motley Fool
Mon, 01/27/20 - 10:50 am
Cue Biopharma
Rubius Therapeutics
CRISPR Therapeutics
Rubius' roller coaster ride set to accelerate with first clinical results
Biopharma Dive
Thu, 10/24/19 - 05:38 pm
Rubius Therapeutics
clinical trials
phenylketonuria
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino
Endpoints
Mon, 07/16/18 - 09:11 am
biotech
IPOs
NASDAQ
Allakos
Constellation Pharma
Crinetics Pharmaceuticals
Replimune
Rubius Therapeutics
A roaring Rubius sets out to snag $1.8B market cap in $200M IPO
Endpoints
Mon, 07/9/18 - 11:22 am
Rubius Therapeutics
IPOs